Drugs Made In America Acquisition Corp. (DMAA) Stock Profile — Insider Trades & Financials

Net Income$2.2M

Market Cap$352.3M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Roger Bendelac

CEO & Executive Director

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Founded: 2024
Headquarters: Fort Lauderdale, Florida, United States
Website: dmaacorp.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-29.81%

ROA?

0.92%

D/E Ratio?

-1.00

📊

Profitability Ratios

Current Ratio?

0.06

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Nov 18, 2025

10-QQ3 20250d after period end

Aug 14, 2025

10-QQ2 20250d after period end

May 20, 2025

10-QQ1 20250d after period end

Mar 31, 2025

10-KQ4 20243d after period end

Loading company sections...

Drugs Made In America Acquisition Corp.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness